Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026KRESLADI™ for severe LAD-I on track for March 28, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results